Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

UnitedHealth, Amedisys and antitrust regulators will have a magistrate judge’s help in hashing out a solution to the DOJ’s ...

A federal judge in Maryland ordered the Justice Department and UnitedHealth Group to begin mediation on Aug. 18.

The U.S. Department of Justice’s (DOJ) lawsuit against Amedisys Inc. (NASDAQ: AMED) and UnitedHealth Group (NYSE: UNH) will ...

Amedisys had a net margin of 3.57% and a return on equity of 12.20%. Sell-side analysts expect that Amedisys will post 4.4 earnings per share for the current year. Hedge Funds Weigh In On Amedisys ...

RBC Capital analyst Ben Hendrix maintained a Buy rating on Amedisys (AMED – Research Report) yesterday and set a price target of $100.00.Stay ...

Highlights,Geode Capital Management increased its stake in Amedisys during the last quarter.,Major financial institutions have added or expanded positions in Amedisys.,The company posted steady ...

It has been about a month since the last earnings report for Amedisys (AMED). Shares have added about 1.3% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...